| AIs | Aromatase inhibitors |
| AIA | Aromatase inhibitor-induced arthralgia |
| AIMSS | Aromatase inhibitor-associated musculoskeletal symptoms |
| AMPK | Adenosine 5′ monophosphate-activated protein kinase |
| Ang | Angiopoietin |
| apo A1 | Apolipoprotein A1 |
| BAP | Bone specific alkaline phosphatase |
| BFI | Brief fatigue inventory |
| BFM | Body fat mass |
| BMD | Bone mineral density |
| BMI | Body mass index |
| BPI-S | Brief Pain Intensity Score |
| BPI-SF | Brief pain inventory–short form |
| BRC | Breast cancer |
| BRCS | Breast cancer survivors |
| BW | Body weight |
| CD19+ | Cluster of differentiation |
| CDSS | Clinical Decision Support System |
| CFS | Cancer Fatigue Scale |
| CoQ10 | Coenzyme Q10 |
| CPIS | Categorical pain intensity scale |
| CRP | C-reactive protein |
| CTX | Serum C-telopeptide |
| CVD | Cardiovascular disease |
| DHA | Docosahexaenoic acid |
| DHEAS | Dehydroepiandrosterone sulfate |
| DPD | Deoxypyridinoline |
| DP | Dried plum |
| EORTC | The European Organization for Research and Treatment of Cancer |
| EORTC QLQ-BR23 | European organization for research and treatment of cancer quality of life questionnaire the breast cancer supplementary module |
| EORTC QLQ-C30 | European organization for research and treatment of cancer quality of life questionnaire core 30 |
| EPA | Eicosapentaenoic acid |
| ER | Estrogen receptor |
| FACT-B | Functional assessment of cancer therapy breast |
| FACT-ES | Functional Assessment of Cancer Therapy–General |
| FMD | Fasting-mimicking diet |
| HADS | Hospital anxiety and depression scale |
| HAQ II scores | Health assessment questionnaire II |
| HC | Hip circumference |
| HCys | Homocysteine |
| HDL | High-density lipoprotein |
| Hif | Hypoxia-inducible factor |
| HOMA-IR | Homeostatic model assessment for insulin resistance |
| HR+ | Hormone-receptor-positive |
| hs-CRP (CRP) | High-sensitivity C-reactive protein |
| IFNγ | Interferone gamma |
| IGF-1 | Insulin-like growth factor 1 |
| IL-1 | Interleukin-1 |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IL-10 | Interleukin-10 |
| IL-15 | Interleukin-15 |
| IL-17 | Interleukin-17 |
| LC | Long chain |
| LCAT | Lecithin: cholesterol acyl transferase |
| LDL | Low-density lipoprotein |
| LDL cholesterol | Low-density lipoprotein cholesterol |
| LPL | Lipoprotein lipase |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MedDiet score | Mediterranean diet score |
| MENQOL | Menopause-specific quality of life |
| MMA | Methylmalonic acid |
| mTOR | Mechanistic (mammalian) target of rapamycin |
| NCI-CTCAE | National Cancer Institute–common toxicity criteria for adverse event |
| NK | Natural killer |
| NKG2A+ | Natural killer group 2 member A |
| NKp30+ | Natural cytotoxicity receptor 3 |
| Nrf2 | Nuclear factor E-2 related factor 2 |
| NS | Not significant |
| OCN | Osteocalcin |
| P1NP | Procollagen type 1 N-terminal propeptide |
| PPARα | Peroxisome proliferator-activated receptor α |
| PRAI | Patient-reported arthralgia inventory |
| PTH | Parathyroid hormone |
| QoL | Quality of life |
| SAA | Serum amyloid A |
| sCTX | Serum C-terminal telopeptide |
| SF-36 | 36-Item Short-Form Survey |
| TG | Triglycerides |
| TAM | Tamoxifen |
| TC | Total cholesterol |
| TG | Triglycerides |
| TGFβ | Transforming growth factor beta |
| TNFR-2 | Tumor necrosis factor receptor 2 |
| TNF-α | Tumor necrosis factor alpha |
| TRAP-5b | Tartrate-resistant acid phosphatase isoform 5b |
| VAS | Visual analog pain scale |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptor |
| WC | Waist circumference |